Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
DOSHISHA, 7% Increase in Ordinary Profit, Record High for The First Time in Five Years, Dividend Raised by 15 yen
7483 DOSHISHA CO.,LTD. 【J-GAAP】
Earnings ReportDOSHISHA CO.,LTD. <7483> [TSE Prime] announced its financial results after the market closed on May 9th (15:30). The consolidated ordinary profit for the fiscal year ending March 2025 increased 11.1% from the previous period to 9.34 billion yen. For the fiscal year ending March 2026, the consolidated ordinary profit is expected to grow by 7.0% to 10 billion yenExpected to reach record high profits for the first time in five years. This will be the fourth consecutive term of revenue and profit growth.
At the same time, the company has decided to increase the dividend this fiscal year to 100 yen, an increase of 15 yen from the previous fiscal year.
In the most recent three-month period, from January to March (4Q), the consolidated ordinary profit increased 43.9% from the same period last year, reaching 1.47 billion yen. The operating profit margin improved from 3.4% in the same period last year to 5.5%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2023 | 105,709 | 8,052 | 8,342 | 5,621 | 164.3 | 65 | May 10, 2023 | J-GAAP |
Mar, 2024 | 105,824 | 7,926 | 8,412 | 5,784 | 169.4 | 75 | May 9, 2024 | J-GAAP |
Mar, 2025 | 113,939 | 8,995 | 9,348 | 6,409 | 185.3 | 85 | May 9, 2025 | J-GAAP |
YoY | +7.7% | +13.5% | +11.1% | +10.8% | +9.3% |
Full Year Results vs. Previous Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2025 Guidance | 110,000 | 9,000 | 9,100 | 6,000 | 172.0 | 85 | Jan 31, 2025 | J-GAAP |
Mar, 2025 Results | 113,939 | 8,995 | 9,348 | 6,409 | 185.3 | 85 | May 9, 2025 | J-GAAP |
Revision Rate | +3.6% | -0.1% | +2.7% | +6.8% | +7.7% |
Current Period Guidance
H1 Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Apr - Sep, 2024 | 54,508 | 4,182 | 4,322 | 2,884 | 84.0 | 40 | Oct 31, 2024 | J-GAAP |
Apr - Sep, 2025 Guidance | 58,300 | 4,700 | 4,800 | 3,200 | 90.6 | 50 | May 9, 2025 | J-GAAP |
YoY | +7.0% | +12.4% | +11.1% | +11.0% | +7.8% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2024 | 105,824 | 7,926 | 8,412 | 5,784 | 169.4 | 75 | May 9, 2024 | J-GAAP |
Mar, 2025 | 113,939 | 8,995 | 9,348 | 6,409 | 185.3 | 85 | May 9, 2025 | J-GAAP |
Mar, 2026 Guidance | 120,000 | 9,800 | 10,000 | 6,700 | 189.7 | 100 | May 9, 2025 | J-GAAP |
YoY | +5.3% | +8.9% | +7.0% | +4.5% | +2.4% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jan - Mar, 2024 | 21,117 | 724 | 1,027 | 814 | 23.8 | 3.4 | May 9, 2024 | J-GAAP |
Apr - Jun, 2024 | 27,869 | 2,416 | 2,516 | 1,678 | 49.2 | 8.7 | Jul 31, 2024 | J-GAAP |
Jul - Sep, 2024 | 26,639 | 1,766 | 1,806 | 1,206 | 35.1 | 6.6 | Oct 31, 2024 | J-GAAP |
Oct - Dec, 2024 | 35,277 | 3,481 | 3,548 | 2,440 | 70.8 | 9.9 | Jan 31, 2025 | J-GAAP |
Jan - Mar, 2025 | 24,154 | 1,332 | 1,478 | 1,085 | 31.4 | 5.5 | May 9, 2025 | J-GAAP |
YoY | +14.4% | +84.0% | +43.9% | +33.3% | +31.5% |
Related Articles
I-ne, Jan-Mar (1Q) Ordinary Profit Increases by 19%
Global Ltd, Jul-Mar (Cumulative 3Q) Ordinary Profit Decreases by 11%, Jan-Mar Ordinary Profit Turns to Loss
Oncolys BioPharma, Jan-Mar (1Q) Net Income Loss Widens
JAPAN CASH MACHINE, 79% Decrease in Ordinary Profit for The Current Fiscal Year
NITTO BOSEKI, 3% Decrease in Ordinary Profit for The Current Fiscal Year, Increased Previous Year's Dividend by 19 yen
Medrx, Jan-Mar (1Q) Ordinary Profit Loss Widens
HIRAKAWA HEWTECH, Last Fiscal Year's Ordinary Profit Exceeds Expectations, 21% Increase in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 2 yen
KOSE, Jan-Mar (1Q) Ordinary Profit Decreases by 50%
SHIMA SEIKI MFG, Returning to Profitability This Year, Dividend Raised by 10 yen
AUTOBACS SEVEN, 8% Increase in Ordinary Profit for The Current Fiscal Year